Using genetic approaches, we reveal that during normal murine development the SHH pathway is first required for normal specification of Rathke's pouch embryonic precursors and subsequently to control their proliferation.
SUMMARY STATEMENT
Using genetic approaches, we reveal that during normal murine development the SHH pathway is first required for normal specification of Rathke's pouch embryonic precursors and subsequently to control their proliferation.
INTRODUCTION
Together, the pituitary gland and hypothalamus serve as the main regulator of the neuroendocrine axis, controlling critical physiological processes such as growth, reproduction, metabolism and stress response. The vertebrate pituitary is comprised of the anterior pituitary (AP), including the anterior and intermediate lobes (AL and IL, respectively) , and the posterior pituitary (PP). The AP derives from Rathke's pouch (RP), a dorsal elevation of the oral ectoderm near the boundary with the pharyngeal endoderm, whilst the PP is of neural origin and originates from a recess of the overlying hypothalamus, the presumptive infundibulum (Davis and Camper, 2007; Rizzoti, 2015; Takuma et al., 1998; Treier et al., 1998) . Progenitors in the periluminal epithelium of RP proliferate rapidly from 12.5 to 14.5 dpc, to subsequently exit the cell cycle and initiate cell-lineage commitment and differentiation into the different hormone-producing cells (Bilodeau et al., 2009; Davis et al., 2011) .
The AP contains six main hormone-secreting cell types: somatotrophs, (growth hormone, GH), lactotrophs, (prolactin, PRL), corticotrophs, (adrenocorticotropic hormone, ACTH), thyrotrophs, (thyroid stimulating hormone, TSH), gonadotrophs, (luteinising hormone, LH and follicle stimulating hormone, FSH) and melanotrophs (melanocyte-stimulating hormone, MSH). In addition, the AP contains Sox2+ve stem cells, which contribute to the postnatal expansion of the gland and organ homeostasis (Andoniadou et al., 2013; Rizzoti et al., 2013) . The PP holds no endocrine cell types, but is instead richly endowed with axonal projections from hypothalamic neurons (Andersen & Rosenfeld, 2001; Castinetti et al, 2011; Kelberman et al., 2009) . The function of the AP is primarily regulated by the parvocellular and magnocellular neurons, which reside in distinct nuclei in the hypothalamus (Andersen and Rosenfeld, 2001; Burbridge et al., 2016; Shimogori et al., 2010) .
RP development is thought to be a step-wise process that requires at least two sequential inductive signals from the diencephalon (Takuma et al., 1998) . First, BMP4 is required for induction and formation of a pouch rudiment and second, FGF8 signalling is necessary for activation of Lhx3 and subsequent development of the pouch rudiment into a definitive RP (Takuma et al., 1998) .
Indeed, genetic evidence suggests that the acquisition of RP progenitor identity depends on the activation of Lhx3 and Lhx4 in the pouch rudiment epithelium at 9.0 dpc (Sheng et al., 1996; Sheng et al., 1997) . Embryos homozygous null for Lhx3 and Lhx4 show early RP developmental arrest, where only a rudimentary pouch is formed. No pituitary tissue is recognisable beyond 15.5 dpc, possibly due to decreased proliferation (Sheng et al., 1997) and/or increased apoptosis (Ellsworth et al., 2008; Raetzman et al., 2002; Zhao et al., 2006) . Furthermore, double homozygous null embryos for Pitx1 and Pitx2, two transcription factors expressed in the oral ectoderm and RP at 9.0 dpc, fail to activate Lhx3/Lhx4 expression, resulting in severe RP developmental arrest (Charles et al., 2005; Suh et al., 2002) .
Several in vitro and in vivo studies have established a critical role for hypothalamic expression of BMP4 and FGFs for activation of Lhx3/Lhx4 expression in RP epithelium (Davis and Camper, 2007; Ericson et al., 1998a; Gleiberman et al., 1999; Norlin et al., 2000; Ohuchi et al., 2000; Ozone et al., 2016; Revest et al., 2001; Sbrogna et al., 2003; Suga et al., 2011; Takuma et al., 1998; Treier et al., 1998; Treier et al., 2001) . In contrast, definitive in vivo evidence for a similar role of SHH is lacking. Genetic experiments in zebrafish and mouse have provided evidence supporting a role for Hedgehog signalling in the proliferation of LHX3+ve/LHX4+ve RP progenitors rather than in the initial induction of RP identity (i.e. activation of Lhx3 and Lhx4 expression) (Dutta et al., 2005; Herzog et al., 2003; Karlstrom et al., 1999; Park et al., 2000; Treier et al., 2001; Wang et al., 2010) .
Over-expression of the SHH inhibitor Hhip under the control the Pitx1 promoter does not prevent the activation of Lhx3/Lhx4 or formation of a definitive RP, but results in pituitary hypoplasia (Treier et al., 1998) . Conversely, over-expression of Shh leads to pituitary hyperplasia, suggesting a proliferative role for SHH on already specified LHX3+ve/LHX4+ve RP progenitors. More recently, the anterior hypothalamic expression of Shh has been conditionally deleted using a specific SOX2-binding enhancer-Cre (SBE2-Cre) (Zhao et al., 2012) . This leads to mis-patterning of the hypothalamus and RP hypoplasia, but Lhx3/Lhx4 expression occurs in RP epithelium. In fact, in some embryos, multiple LHX3+ve/LHX4+ve pouches were observed. Genetic ablation in mice supports a critical role of Gli factors during hypothalamo-pituitary development but the exact mechanisms are still not fully clarified (Park et al., 2000; Wang et al., 2010) .
In this manuscript, we have used genetic approaches in mouse to demonstrate that, in addition to promoting RP progenitor proliferation, hypothalamic Shh expression is essential for the initial activation of Lhx3/Lhx4 transcription in RP epithelium and formation of a definitive pouch. In addition, we show that the anterior hypothalamus fails to differentiate.
RESULTS

The SHH pathway is active throughout normal pituitary development in mice and humans
First, we performed a detailed study to assess the expression of Shh/SHH and its effector target genes Gli1 and Ptch1 throughout pituitary development in both mice and humans.
At 9.5 and 10.5 dpc, Shh transcripts were detected within a rostral neural domain, including the developing anterior hypothalamus and ventral telencephalon, and a caudal domain, encompassing the posterior hypothalamus, possibly the mammillary area, and adjacent floorplate of the midbrain.
There is a Shh-negative area between the mammillary region and anterior hypothalamus, likely corresponding to the tuberal hypothalamus ( Fig. 1 A,B) . At these stages, Shh expression was also observed in the pharyngeal endoderm immediately posterior to the developing RP, which was devoid of any Shh expression ( Fig. 1 A,B) . Although Shh expression was initially reported to be expressed in the oral ectoderm of wild-type embryos at 9.5-10.5 dpc (Treier et al., 1998; Treier et al., 2001 ), we could not detect the presence of Shh transcripts in this layer medially between 9.5 and 10.5 dpc, in agreement with a recent report (Zhao et al., 2012) . To clarify further this discrepancy and assess the timing of Shh expression in the oral ectoderm, we performed a detailed expression analysis on histological sections of wildtype embryos from 16-46 somites (i.e. 9.0 to 11.5 dpc; (Hogan et al., 1994) (Fig. S1) . By staging the embryos by somite number, we aimed to accurately pin-point the onset of Shh expression in this tissue. This study revealed that Shh mRNA is first detected in the lateral oral ectoderm adjacent to the developing RP in 33 somite-stage embryos (10.0 dpc) (Fig.   S1E¢¢ ). Strong expression in the lateral oral ectoderm was more evident at 42 and 46 somites (11-11.5 dpc) (Fig. S1G¢¢,H-H¢¢ ) . RNAScope in situ hybridisation, enabling sensitive detection of mRNA expression up to single molecule resolution, confirmed the absence of Shh expression in the oral ectoderm at 16 somites ( Fig. S1A-A¢¢) (Wang et al., 2012) .
Supporting the RNA expression pattern, SHH was strongly detected in the anterior hypothalamus, pharyngeal endoderm and a weak but consistent signal was also observed in the oral ectoderm and anterior part of RP epithelium, suggesting potential spreading of SHH from the preoptic area towards the developing RP (Fig. 1 G,H) . From 11.5 to 14.5 dpc, Shh transcripts were detected within the developing hypothalamus ( Fig. 1C-E,I-K) and by 18.5 dpc, signal was restricted to the ventricular zone of the 3 rd ventricle (Fig. 1F) . No obvious expression was detected in the developing pituitary by digoxigenin-labelled Shh riboprobes from 9.5-18.5 dpc (Fig. 1F) . In contrast, SHH protein was clearly observed in single cells within the anterior pituitary at 18.5 dpc (Fig. 1L) . In agreement with this, Shh transcripts were detected in sporadic single cells within the anterior pituitary at 18.5 dpc by RNAscope in situ hybridisation (Supp. Fig. 2A,B) .
To assess the activation of the SHH pathway, the expression of the target genes Gli1 and Ptch1 was analysed by in situ hybridisation. At 9.5 dpc, Gli1 transcripts were detected broadly throughout the developing hypothalamus and RP ( Fig. 1M ) and at 10.5 and 12.5 dpc, RP epithelium expressed Gli1 robustly ( Fig. 1N-P) . By 14.5 dpc, Gli1 transcripts were found mostly in the dorsal region of the periluminal epithelium of RP and by 18.5 dpc, expression was restricted to the marginal zone, a region of the anterior pituitary ventrally lining the cleft that is highly enriched for Sox2+ve stem cells (Fig. 1Q,R) . However, in the hypothalamus, Gli1 expression could not be detected in the ventral midline of the anterior hypothalamus or developing infundibulum from 10.5 dpc onwards, but signal was strong in the posterior hypothalamus, possibly including the prospective caudal tuberal and mammillary area (Fig. 1N) . At 18.5 dpc, Gli1 expression was restricted to the ventricular zone of the 3 rd ventricle (Fig. 1R) .
Ptch1 expression was also very dynamic. A 9.5 dpc, Ptch1 transcripts were weakly detected in the posterior (forming mammillary region), strongly detected in the anterior hypothalamus and barely detected in the tuberal hypothalamus -patterns that became even more pronounced by 10.5 dpc (Fig. 1S,T) . Strong Ptch1 signal was detected in the hypothalamus from 11.5-14.5 dpc, except for the infundibulum, and by 18.5 dpc, the hypothalamic signal was mostly detected in the ventricular zone of the 3 rd ventricle (Fig. 1U-X) . Within the developing RP, Ptch1 expression was detected broadly in the epithelial progenitors at 9.5 dpc, but became progressively restricted to the ventral areas of RP, adjacent to the oral epithelium and pharyngeal endoderm by 11.5 dpc ( Fig. 1S-U) . At 12.5 dpc, only a small region of the periluminal epithelium of RP was positive for Ptch1 transcripts (Fig. 1V) .
Subsequently, at 14.5 and clearly at 18.5 dpc, Ptch1 transcripts were observed only in the marginal zone ( Fig. 1 W,X) .
At Carnegie stage 15 (CS15) in human fetal embryos, SHH transcripts and protein were identified in the anterior hypothalamus and pharyngeal endoderm, but were absent from the developing RP, similar to the mouse (Supp. Fig. 3A-D) . GLI1 transcripts were observed throughout the developing hypothalamus (Supp. Fig. 3E,F) and RP, suggesting activation of the pathway.
Together, these expression studies suggest that the SHH pathway is activated preferentially in regions containing undifferentiated precursors/stem cells, such as the RP periluminal epithelium at early stages of development and the marginal zone lining the cleft at 18.5 dpc. In addition, these analyses demonstrate the expression of SHH protein in tissues adjacent to the developing RP at early developmental stages, including the developing hypothalamus and pharyngeal endoderm suggesting that signalling from these domains may be required to activate the pathway in RP progenitors.
Deletion of Shh in the Hesx1 cell lineage leads to pituitary aplasia in Hesx1
Cre/+ ;Shh fl/-mutants
The Hesx1-Cre mouse line drives Cre-mediated recombination in the anterior neural plate, including the prospective telencephalon and prospective anterior hypothalamus, as well as RP epithelium from 9.0 dpc (Jayakody et al., 2012) . We generated Hesx1 Cre/+ ;Shh fl/-mice to study the consequences of early Shh deletion in the anterior hypothalamic area, as Shh is not expressed in RP epithelium and expression in the oral ectoderm occurs from 10.0 dpc.
Genotypic analysis of embryos between 9.5 and 18.5 dpc revealed no statistical deviation from the expected Mendelian ratios ( 
Hesx1
Cre/+ ;Shh fl/-mutant embryos showed mild forebrain defects from 10.5 dpc, including a reduction in the size of the telencephalic vesicles, and by 11.5 dpc, loss of pigmented retina ( Fig. 
S4A-C).
A very small proportion of the mutant embryos showed more severe defects, including holoprosencephaly at 10.5 dpc (n=4 out of 28, Fig. S4D-F) . At 18.5 dpc, severe craniofacial defects as well as telencephalic and hypothalamic abnormalities were observed in all mutants analysed (n=3, Fig. S5A-H) . Pituitary tissue could not be identified morphologically at this stage in serial section analysis of the mutants (Fig. S5I-L) .
Immunostaining against GH and PIT1, which label most of the pituitary cells at 18.5 dpc, revealed the complete lack of expression in serial sections in Hesx1 Cre/+ ;Shh fl/-mutants at 18.5 dpc (Fig. S6) . To further characterise the observed pituitary aplasia, we analysed embryos from 9.5 dpc onwards by haematoxylin-eosin staining. At 9.5 dpc, control embryos showed a close association between the evaginating RP epithelium and the floor of the neuroepithelium of the prospective infundibular area ( Fig. 2A) . In contrast, this intimate association was often lost in Hesx1 Cre/+ ;Shh fl/-mutant embryos and mesenchymal tissue was observed intercalated between RP and the neural epithelium and appeared to be over-grown (Fig. 2B) . Reduced size and failure to contact the infundibular area was more obvious at 10.5 dpc and by 11.5 dpc, RP was severely hypoplastic and no infundibulum could be observed ( Fig. 2 C-F (Fig. 4E,F) . Loss of SHH in the anterior hypothalamus and ectopic SHH expression in the posterior RP were also confirmed at the protein level by specific immunofluorescence staining (Fig. 4G,H) . In agreement with the deletion of Shh, expression of Ptch1 was lost in the anterior, yet present in the posterior hypothalamus in
Hesx1
Cre/+ ;Shh fl/-mutants (Fig. 4K,L) . Loss of Ptch1 and Gli1 expression was also observed in the anterior region of the developing RP, with transcripts detectable only in the posterior RP (Fig. 4I-L) .
Expression of Shh was observed in the oral ectoderm of the Hesx1 Cre/+ ;Shh fl/-mutants at 11.5 dpc, invading the epithelium of a rudimentary RP (Fig. 4M,N) . These results demonstrate that, in addition to severe hypothalamic, telencephalic and craniofacial defects at late gestation, the early loss of Shh expression in the anterior hypothalamus results in abnormal development of RP from 9.5 dpc with pituitary aplasia from 12.5 dpc.
Anterior hypothalamus marker expression is lost in in Hesx1
Cre/+ ;Shh fl/-mutants Fgf8 and Bmp4 are essential signals controlling hypothalamus and RP development (Davis and Camper, 2007; Ericson et al., 1998) . Transcripts for these secreted factors were normally expressed in the posterior hypothalamus at 10.5 dpc, which includes the tuberal hypothalamus and primordium of the infundibulum, but their expression domains do not reach the anterior hypothalamic area, where Shh is expressed (Fig. 5A,C) . In contrast, the expression domains of these critical hypothalamic signals were extended anteriorly in the Hesx1 Cre/+ ;Shh fl/-mutants, invading the domain where Shh was detected in the control embryos (Fig. 5B,D) . The expression domains of Tbx2 and Tbx3, two negative regulators of Shh expression (Trowe et al., 2013) , were similar between
Hesx1
Cre/+ ;Shh fl/-mutants and controls, although Tbx3 expression domain appeared slightly expanded ( Fig. 5E-H) . Nkx2.1, another critical regulator of hypothalamic development (Kimura et al., 1996; Takuma et al., 1998) , was broadly expressed throughout the hypothalamus in control embryos, but its expression domain was shortened in Hesx1 Cre/+ ;Shh fl/-mutants with a lack of expression in the anterior hypothalamus ( Fig. 5I,J) . Otx2 is an important transcription factor required for normal development of the hypothalamus and pituitary (Acampora et al., 1995; Mortensen et al., 2015; Tajima et al., 2009 either by in situ hybridisation or immunostaining from 9.0 dpc (16 somites) to 11.5 dpc ( Fig. 6A- 
D,G,H,K,L,M-P).
Despite the failure to activate Lhx3 and Lhx4 expression, other RP markers such as PITX1, SOX2, Pitx2, Pax6, Six3, Islet1 and Wnt4 were found to be expressed in the developing RP in
Hesx1
Cre/+ ;Shh fl/-mutants with no apparent differences compared to control embryos ( Fig. 6E,F,I ,J,Q-
X and Fig. 4S,T,W,X).
The loss of pituitary tissue in Lhx3 -/-;Lhx4 -/-double mutants has been attributed to decreased proliferation and/or increased apoptosis of RP progenitors. Immunostaining against activated
Caspase-3, a marker of apoptotic cells (Wolf et al., 1999) , revealed the presence of only a few scattered positive cells in RP at 11.5 dpc, and none at 9.5 or 10.5 dpc ( Fig. 7H-M) . A small but significant decrease in the mitotic index, as assessed using the mitotic marker phospho-histone H3 (Hendzel et al., 1997) , was observed in Hesx1 Cre/+ ;Shh fl/-mutants at 11.5 dpc ( Fig. 7A-G suggesting a caudal extension of the Bmp4+ve oral ectoderm into the developing pouch (Fig. 5D) .
Likewise, the expression of TCF4 ( Fig. 5O) and SHH ( Fig. 4E ,G) was detected in the pharyngeal endoderm, but not in RP in control embryos at 10.5 dpc. In contrast, an anterior expansion of both TCF4 and SHH expression domain was observed in the Hesx1 Cre/+ ;Shh fl/-mutants, with strong signal detectable in the posterior region of RP adjacent to the pharyngeal endoderm (Fig. 5P, Fig. 4F, H) .
Finally, these observations were further corroborated with other markers, such as N-and E-cadherin.
In normal embryos at 10.5 dpc, E-cadherin is expressed in the oral ectoderm, pharyngeal endoderm but not in RP, which expresses N-cadherin (Fig. 5U) . Anterior N-cadherin expression was lost in the
Hesx1
Cre/+ ;Shh fl/-mutant RP, which expressed E-cadherin ( 
Cre/+ ;Ptch1 fl/fl mice die perinatally ( Table 2 ) with severe forebrain and craniofacial defects ( Fig. S10) . Haematoxylin-eosin staining revealed no gross morphological defects in the developing RP or infundibulum between Hesx1 Cre/+ ;Ptch1 fl/fl mutants and control embryos at 10.5 dpc (Fig. 8A,B) . The first clear evidence of a morphological defect was observed at 12.5 dpc (Fig. 8C,D) , when the developing anterior lobe appeared hyperplastic in Hesx1 Cre/+ ;Ptch1 fl/fl mutants compared with controls. Pituitary hyperplasia was more evident at 14.5 and 18.5 dpc, with an enlargement of the cleft and thickening of the anterior lobe in mutants relative to controls ( Fig. 8E-H) . Up-regulation of the SHH pathway in RP was observed from 10.5 dpc ( Fig. 8I- (Fig. S11) . Patterning of the developing hypothalamus and specification of RP at 10.5 dpc occurred normally in Hesx1 Cre/+ ;Ptch1 fl/fl mutants compared with control embryos (Fig. S12) . Likewise, cell commitment and differentiation of hormone-producing cells was not prevented in the Hesx1 Cre/+ ;Ptch1 fl/fl mutants ( Fig. S13 and S14 ).
Over-activation of the SHH pathway results in expansion of the Sox2+ve stem cell compartment in Hesx1
Cre/+ ;Ptch1 fl/fl mutants At 14.5 dpc, the expression pattern of SOX2 was comparable between genotypes ( Fig. 9A,   B ). In contrast, SOX9 expression in the developing AL appeared elevated in the Hesx1 Cre/+ ;Ptch1 fl/fl mutants compared with controls ( Fig. 9E,F) . At 18.5 dpc, numbers of SOX2 and SOX9+ve cells were significantly increased in the anterior pituitary and marginal zone of Hesx1 Cre/+ ;Ptch1 fl/fl embryos compared with controls ( Fig. 9C, D, G-I ). It has previously been shown that pituitary cells with clonogenic potential in vitro are contained within the SOX2+ve cell population (Andoniadou et al., 2012; Andoniadou et al., 2013; Vankelecom, 2010 In conclusion, our data support the mainstream role of the SHH pathway in the control of cell proliferation during pituitary development and in addition, have revealed an essential role for SHH in the specification of RP progenitors in vivo. 
MATERIALS AND METHODS
Mice and human pituitaries
Histology and in situ hybridisation on histological sections
Histological sections were stained using Harris' haematoxylin for morphology as previously described (Andoniadou et al., 2011) . In situ hybridisation was performed on paraffin-embedded histological sections as previously described (Sajedi et al., 2013) . For further details, supplementary Materials and Methods.
Cell counting in vivo
Cell counts in vivo were performed in 4-6 non-consecutive histological sections immunostained with 
Immunofluorescence and RNAScope in situ hybridisation
Section immunostaining was performed as previously described (Andoniadou et al., 2013 
Assessment of clonogenic potential
Clonogenic assays were performed on murine anterior pituitaries as previously described (Andoniadou et al., 2012; Andoniadou et al., 2013) . For further details, supplementary Materials and Methods.
Statistics
Mendelian ratios were calculated using the chi-squared test. Clonogenic potential of 18.5 dpc pituitaries and total cells counts in vivo were evaluated using an un-paired t-test.
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